2023 North America Conference on Lung Cancer (NACLC) Highlights Webinar-2023 NACLC Highlights Webinar

Video Transcription

Video Summary

The ISLC North American Conference in Lung Cancer Highlights recently took place, featuring presentations on various topics related to lung cancer. Dr. Luis Reyes, a thoracic oncologist, served as the moderator for the seminar. The conference began with a talk on advancing health equity through engagement, focusing on the disparities in lung cancer outcomes among different racial and ethnic groups. The speaker discussed how structural racism and social determinants of health contribute to these inequities and proposed solutions at various levels, including policy, community, institutional, interpersonal, and individual. <br /><br />Other presentations covered topics such as biomarker testing in early-stage lung cancer, the efficacy of targeted therapies, and the use of nutrition as an intervention in lung cancer care. One study highlighted the importance of appropriate biomarker testing for EGFR and PDL1 expression before initiating adjuvant therapy in early-stage non-small cell lung cancer. Another study examined the use of the ALK inhibitor electinib in resected non-small cell lung cancer, showing a significant improvement in disease-free survival compared to chemotherapy. <br /><br />Dr. Jyoti Patel delivered a keynote address discussing the role of perioperative therapy in improving outcomes for early-stage lung cancer patients. She emphasized the importance of individualized approaches based on patient response, such as pathologic complete response, and highlighted ongoing research efforts in this area. The conference provided valuable insights and updates on the latest advancements in lung cancer research and treatment, demonstrating the importance of multidisciplinary care and addressing health disparities in lung cancer outcomes.

Meta Tag

Concept IASLC North American Lung Cancer Conference

Concept Health Equity

Concept Zongertinib

Concept MARIPOSA Trial

Concept Early-Stage Non-Small Cell Lung Cancer

Keywords

ISLC North American Conference

lung cancer

health equity

disparities

structural racism

social determinants of health

biomarker testing

targeted therapies

nutrition intervention

IASLC North American Lung Cancer Conference

Health Equity

Zongertinib

MARIPOSA Trial

Early-Stage Non-Small Cell Lung Cancer